The FDA has cleared Reverse Medical to market its MVP micro vascular plug, which aids in reducing blood flow in patients undergoing peripheral artery embolization. The company also recently obtained regulatory approval for the product in Europe, where the first patients were treated with the device in June.
Reverse Medical gains FDA clearance for embolization device
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|